Literature DB >> 25892876

Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.

Jian-Wei Zhang1, Yun-Mian Chu1, Zhong-Min Lan1, Xiao-Long Tang1, Ying-Tai Chen1, Cheng-Feng Wang1, Xu Che1.   

Abstract

AIM: To investigate the prognostic value of metastatic lymph node ratio (MLNR) in extrahepatic cholangiocarcinoma (ECC) patients undergoing radical resection.
METHODS: Seventy-eight patients with ECC were enrolled. Associations between various clinicopathologic factors and prognosis were investigated by Kaplan-Meier analyses. The Cox proportional-hazards model was used for multivariate survival analysis.
RESULTS: The overall three- and five-year survival rates were 47.26% and 23.99%, respectively. MLNR of 0, 0-0.2, 0.2-0.5, and > 0.5 corresponded to five-year survival rates of 28.59%, 21.60%, 18.84%, and 10.03%, respectively. Univariate analysis showed that degree of tumor differentiation, lymph node metastasis, MLNR, tumor-node-metastasis (TNM) stage, and margin status were closely associated with postoperative survival in ECC patients (P < 0.05). Multivariate analysis showed that MLNR and TNM stage were independent prognostic factors after pancreaticoduodenectomy (HR = 2.13, 95%CI: 1.45-3.11; P < 0.01; and HR = 1.97, 95%CI: 1.17-3.31; P = 0.01, respectively). The median survival time for MLNR > 0.5, 0.2-0.5, 0-0.2, and 0 was 15 mo, 24 mo, 23 mo, and 35.5 mo, respectively. There were statistical differences in survival time between patients with different MLNR (χ(2) = 15.38; P < 0.01).
CONCLUSION: MLNR is an independent prognostic factor for ECC patients after radical resection and is useful for predicting postoperative survival.

Entities:  

Keywords:  Cholangiocarcinoma; Metastatic lymph node; Prognosis; Surgery

Mesh:

Year:  2015        PMID: 25892876      PMCID: PMC4394087          DOI: 10.3748/wjg.v21.i14.4255

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  Preoperative serum CA19-9 levels is an independent prognostic factor in patients with resected hilar cholangiocarcinoma.

Authors:  Wen-Ke Cai; Jia-Ji Lin; Gong-Hao He; Hua Wang; Jun-Hua Lu; Guang-Shun Yang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  SOX4 is associated with poor prognosis in cholangiocarcinoma.

Authors:  Weishan Wang; Jing Zhang; Xuemei Zhan; Tao Lin; Muyi Yang; Jing Hu; Bo Han; Sanyuan Hu
Journal:  Biochem Biophys Res Commun       Date:  2014-08-30       Impact factor: 3.575

3.  Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Naru Kondo; Naoya Nakagawa; Takeshi Muto; Hayato Sasaki; Kazuhide Urabe; Taijiro Sueda
Journal:  J Gastrointest Surg       Date:  2013-08       Impact factor: 3.452

4.  Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma.

Authors:  D Tamandl; K Kaczirek; B Gruenberger; C Koelblinger; J Maresch; R Jakesz; T Gruenberger
Journal:  Br J Surg       Date:  2009-08       Impact factor: 6.939

5.  Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasuo Hayashidani; Yasushi Hashimoto; Hiroyuki Nakamura; Akira Nakashima; Taijiro Sueda
Journal:  Ann Surg       Date:  2009-12       Impact factor: 12.969

Review 6.  Epidemiology of cholangiocarcinoma: an update focusing on risk factors.

Authors:  Hai-Rim Shin; Jin-Kyoung Oh; Eric Masuyer; Maria-Paula Curado; Veronique Bouvard; Yue-Yi Fang; Surapon Wiangnon; Banchob Sripa; Sung-Tae Hong
Journal:  Cancer Sci       Date:  2009-12-04       Impact factor: 6.716

7.  Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.

Authors:  Massimo Falconi; Stefano Crippa; Ismael Domínguez; Giuliano Barugola; Paola Capelli; Stefano Marcucci; Stefania Beghelli; Aldo Scarpa; Claudio Bassi; Paolo Pederzoli
Journal:  Ann Surg Oncol       Date:  2008-08-20       Impact factor: 5.344

8.  Autophagy may promote carcinoma cell invasion and correlate with poor prognosis in cholangiocarcinoma.

Authors:  Takeo Nitta; Yasunori Sato; Xiang Shan Ren; Kenichi Harada; Motoko Sasaki; Satoshi Hirano; Yasuni Nakanuma
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

9.  Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion.

Authors:  Hee Joon Kim; Choong Young Kim; Young Hoe Hur; Yang Seok Koh; Jung Chul Kim; Hyun Jong Kim; Chol Kyoon Cho
Journal:  Surg Today       Date:  2014-02-18       Impact factor: 2.549

10.  The ratio between metastatic and examined lymph nodes (N ratio) is an independent prognostic factor in gastric cancer regardless of the type of lymphadenectomy: results from an Italian multicentric study in 1853 patients.

Authors:  Alberto Marchet; Simone Mocellin; Alessandro Ambrosi; Paolo Morgagni; Domenico Garcea; Daniele Marrelli; Franco Roviello; Giovanni de Manzoni; Annamaria Minicozzi; Giovanni Natalini; Francesco De Santis; Luca Baiocchi; Arianna Coniglio; Donato Nitti
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

View more
  2 in total

1.  Expression and prognostic value of glutamate dehydrogenase in extrahepatic cholangiocarcinoma patients.

Authors:  Zheng Su; Gaojie Liu; Tingfeng Fang; Ketao Zhang; Shanglin Yang; Huayao Zhang; Yang Wang; Zejian Lv; Jianping Liu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

2.  Comparison of Four Lymph Node Stage Methods for Predicting the Prognosis of Distal Cholangiocarcinoma Patients After Surgery.

Authors:  Xiuyi Huang; Xiaoya Niu; Zhen You; Youlin Long; Fan Luo; Hui Ye
Journal:  Front Oncol       Date:  2021-12-03       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.